These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Achyuthan KE, Dobson JV, Greenberg CS. Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839 [Abstract] [Full Text] [Related]
3. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin. Valnickova Z, Enghild JJ. J Biol Chem; 1998 Oct 16; 273(42):27220-4. PubMed ID: 9765243 [Abstract] [Full Text] [Related]
4. Characterization of thrombospondin as a substrate for factor XIII transglutaminase. Lynch GW, Slayter HS, Miller BE, McDonagh J. J Biol Chem; 1987 Feb 05; 262(4):1772-8. PubMed ID: 2879842 [Abstract] [Full Text] [Related]
5. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Jensen PH, Lorand L, Ebbesen P, Gliemann J. Eur J Biochem; 1993 May 15; 214(1):141-6. PubMed ID: 8099547 [Abstract] [Full Text] [Related]
6. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. Borth W, Chang V, Bishop P, Harpel PC. J Biol Chem; 1991 Sep 25; 266(27):18149-53. PubMed ID: 1680857 [Abstract] [Full Text] [Related]
8. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin. Matsuka YV, Anderson ET, Milner-Fish T, Ooi P, Baker S. Biochemistry; 2003 Dec 16; 42(49):14643-52. PubMed ID: 14661977 [Abstract] [Full Text] [Related]
18. Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase. Lee KN, Lee CS, Tae WC, Jackson KW, Christiansen VJ, McKee PA. J Biol Chem; 2000 Dec 01; 275(48):37382-9. PubMed ID: 10958788 [Abstract] [Full Text] [Related]
19. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase. de Agostini A, Patston PA, Marottoli V, Carrel S, Harpel PC, Schapira M. J Clin Invest; 1988 Aug 01; 82(2):700-5. PubMed ID: 2457036 [Abstract] [Full Text] [Related]